Barclays Maintains an 'Equalweight' on Lincare Holdings (LNCR); Six-Month Delay in Round 2 DME Competitive Bidding a Clear Positive
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Lincare Holdings (NASDAQ: LNCR), PT increased to $34.
Barclays analyst says, "Yesterday, at the DME ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Yesterday, at the DME ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
